Previsioni di mercato della bioproduzione per il Nord America fino al 2030 - Analisi regionale - per prodotto (prodotti biologici e biosimilari, vaccini, terapie cellulari e genetiche, terapie con acidi nucleici e altri), applicazione (artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri) ), apparecchiature (apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori) e utente finale (aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri)
La crescente adozione di medicinali rigenerativi alimenta il mercato della bioproduzione in Nord America
Le terapie rigenerative aiutano nella rigenerazione di cellule, tessuti e organi per ripristinare le loro funzioni. Ogni anno vengono presentate alla Food and Drug Administration (FDA) numerose richieste di medicina rigenerativa per studi clinici sull’uomo. Secondo l’Alliance for Regenerative Medicine, nel 2019 (Q3), erano in corso a livello globale 1.052 studi clinici che utilizzavano la medicina rigenerativa; Nel 2019 erano in corso 218 studi sulla terapia cellulare (41 Fase I, 147 Fase II, 30 Fase III). Si stanno facendo rapidi progressi nelle medicine rigenerative per fornire soluzioni efficaci alle condizioni croniche. La terapia cellulare è uno dei segmenti in più rapida crescita nel campo della medicina rigenerativa. Kymriah di Novartis è stata la prima soluzione di terapia cellulare offerta per il trattamento della leucemia acuta a cellule B. Inoltre, RepliCel, un fornitore di medicina rigenerativa, ha in cantiere un\'ampia gamma di prodotti di medicina rigenerativa, con tre prodotti RCH-01, RCS-01 e RCT-01 in fase di sviluppo. Inoltre, Sernova è impegnata nello sviluppo di tecnologie di medicina rigenerativa e dispone di un’enorme pipeline di prodotti per condizioni come il diabete, l’emofilia A e l’ipertiroidismo. Pertanto, la crescente adozione di farmaci rigenerativi sta guidando il mercato della bioproduzione.
Panoramica del mercato della bioproduzione in Nord America
Il mercato della bioproduzione in Nord America è suddiviso in Stati Uniti, Canada e Messico. In Messico, la domanda di terapia cellulare è piuttosto notevole a causa del crescente turismo medico per la terapia con cellule staminali. Il mercato della bioproduzione in Nord America ha rappresentato la quota di mercato maggiore nel 2022 a causa della crescente incidenza di diabete e infertilità, nonché dell’aumento degli sviluppi di prodotti biosimilari.
La crescente incidenza di disturbi genetici e cellulari sta portando a una crescente domanda di terapie cellulari. Un rapporto PhRMA del 2020 sulla pipeline di terapia cellulare e genica ha rivelato che ci sono 400 terapie cellulari e geniche in fase di sviluppo per colpire una varietà di malattie e condizioni, dal cancro ai disturbi genetici alle condizioni neurologiche negli Stati Uniti. A febbraio 2020, nove prodotti di terapia cellulare o genica erano stati approvati negli Stati Uniti per il trattamento del cancro, delle malattie degli occhi e delle malattie ereditarie rare. Inoltre, un numero crescente di start-up stanno innovando le terapie cellulari nel paese.
Entrate e previsioni del mercato della bioproduzione in Nord America fino al 2030 (milioni di dollari)
Segmentazione del mercato della bioproduzione in Nord America
Il mercato della bioproduzione in Nord America è classificato in prodotto, applicazione, attrezzatura, utente finale e paese.
In base al prodotto, il mercato della bioproduzione del Nord America è segmentato in prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri. Il segmento dei prodotti biologici e biosimilari ha detenuto la maggiore quota di mercato della bioproduzione in Nord America nel 2022.
In termini di applicazione, il mercato della bioproduzione in Nord America è segmentato in artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri. Il segmento del cancro deteneva la quota maggiore del mercato della bioproduzione del Nord America nel 2022.
In base alle apparecchiature, il mercato della bioproduzione del Nord America è suddiviso in apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori. Il segmento dei materiali di consumo e degli accessori ha detenuto la quota maggiore del mercato della bioproduzione del Nord America nel 2022.
In termini di utente finale, il mercato della bioproduzione del Nord America è classificato in aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri. Il segmento delle aziende biofarmaceutiche deteneva la maggiore quota di mercato della bioproduzione in Nord America nel 2022.
Per paese, il mercato della bioproduzione in Nord America è segmentato in Stati Uniti, Canada e Messico. Gli Stati Uniti hanno dominato la quota di mercato della bioproduzione del Nord America nel 2022.
Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Lonza Group AG, Merck KGaA, Sartorius AG e Thermo Fisher Scientific Inc. sono alcuni delle aziende leader operanti nel mercato della bioproduzione del Nord America.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - North America Market Analysis
5.1 North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030
6. North America Bioproduction Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Bioproduction Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Bioproduction Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Bioproduction Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Bioproduction Market – Revenue and Forecast to 2030 – Country Analysis
10.1 North America: Bioproduction Market
10.1.1 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1 Overview
10.1.1.2 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3 US: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.4 US: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.5 US: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.6 US: Bioproduction Market, by End User, 2020–2030 (US$ Million)
10.1.1.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.2.4 Canada: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.2.5 Canada: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.2.6 Canada: Bioproduction Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.3.4 Mexico: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.3.5 Mexico: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.3.6 Mexico: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11. Bioproduction Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. North America Bioproduction Market Segmentation
Table 2. North America Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 3. US Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. US Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. North America Bioproduction Market Segmentation, By Country
Figure 2. North America Bioproduction Market: Key Industry Dynamics
Figure 3. North America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030
Figure 5. North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Bio-Rad Laboratories Inc
2. Danaher Corp
3. F. Hoffmann-La Roche Ltd
4. Lonza Group AG
5. Merck KGaA
6. Sartorius AG
7. Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.